NVAX

7.4703.24%
MJ

Mark J. Casey

Executive VP, Chief Legal Officer & Corporate Secretary

Mr. Mark J. Casey, J.D., Esq., serves as Executive Vice President, Chief Legal Officer at Novavax, Inc. since December 2023 and serves as its Company Secretary since December 11, 2023. He served as Executive Vice President and Chief Legal Officer at Mallinckrodt plc since August 2019 until August 2022. He joined Mallinckrodt in February 2018, where he served as its General Counsel since February 1, 2018 until August 2019. Mr. Casey is also responsible for the Company government affairs, policy and patient advocacy functions, as well as the Company Specialty Generics business. He served as Senior Vice President, General Counsel and Secretary at Idera Pharmaceuticals, Inc, since June 29, 2015 until January 31, 2018. Mr. Casey also served as Senior Vice President, Chief Administrative Officer, General Counsel & Secretary of Hologic, Incorporated("Hologic") from March 2012 to December 2014 and as Senior Vice President, General Counsel & Secretary at Hologic from October 2007 to February 2012. Mr. Casey served as an Assistant Secretary at Hologic Inc. Mr. Casey joined Cytyc Corporation in 2002 and served as its Deputy General Counsel and Chief Patent Counsel. He served as Vice President, Deputy General Counsel and Chief Patent Counsel of Cytyc Corporation. Mr. Casey served as Attorney of Boston Scientific from 1998 to 2002 and EMC Corporation from 1996 to 1998. He served as Senior Patent Counsel for at Boston Scientific. Mr. Casey joined Digital Equipment Corporation's (DEC) law department in 1992, where he served as its Attorney from 1995 to 1996. Mr. Casey held various engineering positions with DEC and AT&T Network Systems from 1985 to 1992. He is a past board member of AdvaMedDx. Mr. Casey holds a B.S. in Electrical Engineering from Syracuse University and a J.D. from Suffolk University Law School.

Positions